BTCS · BTCS Inc. · Insider Trading

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $1.18 to $1.301 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $1.12 to $1.19 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $1.10 to $1.165 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $1.155 to $1.25 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $1.22 to $1.371 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

The grant of Incentive Stock Options were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

The reported securities vest on December 31, 2026, subject to continued employment with the Issuer on the vesting date.

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Units"). The grant of Units were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder. 524,625 shares are subject to shareholder approval and vest in equal annual increments over a period of five years with the first vesting on January 1, 2027. The remaining 524,618 shares are subject to multiple stock price and market cap vesting thresholds.

Not applicable.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Units"). The grant of Units were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder. 524,625 shares are subject to shareholder approval and vest in equal annual increments over a period of five years with the first vesting on January 1, 2027. The remaining 524,618 shares are subject to multiple stock price and market cap vesting thresholds.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

The grant of Incentive Stock Options were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

The reported securities vest on December 31, 2026, subject to continued employment with the Issuer on the vesting date.

Not applicable.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

Not applicable.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock ("Units"). The grant of Units were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder. 1,348,485 shares are subject to shareholder approval and vest in equal annual increments over a period of five years with the first vesting on January 1, 2027. The remaining 1,348,485 shares are subject to multiple stock price and market cap vesting thresholds.

Not applicable.

Includes shares of common stock issuable upon vesting of restricted stock units.

The grant of Incentive Stock Options were approved by the Issuer's Board of Directors and exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

The reported securities vest on December 31, 2026, subject to continued employment with the Issuer on the vesting date.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder.

Not applicable.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The shares were purchased through the Reporting Person's SEP IRA.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $2.74 to $3.00 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $4.67 to $4.88 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $4.015 to $4.24 inclusive. The reporting person undertakes to provide to BTCS Inc., any security holder of BTCS Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The stock options vest on December 31, 2026, subject to continued employment with the Company on the vesting date.

The stock options vest on December 31, 2026, subject to continued employment with the Company on the vesting date.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $6.00 to $6.025, inclusive. The reporting person undertakes to provide to BTCS, Inc., any security holder of BTCS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence. The securities were sold under a 10b5-1 plan.

Not applicable.

The stock options vested as follows: 300,000 options vested on January 1, 2022, and the remaining options vested based upon certain performance milestones involving the issuer's stock price.

Not applicable.

The stock options vested as follows: 140,000 options vested on January 1, 2022 and the remaining options vested based upon certain performance milestones involving the issuer's stock price.

On July 9, 2025, the reporting person exercised options to purchase 750,000 shares of the issuer's common stock at an exercise price of $1.90 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 241,116 of the option shares to pay the exercise price and issuing to the reporting person the remaining shares.

Represents shares of common stock acquired upon exercise of 750,000 stock options with an exercise price of $1.90 per share. The number of shares issued was calculated by multiplying the number of options exercised by the preceding day's closing stock price of $5.91 to determine the total stock value, then subtracting the aggregate exercise price, and dividing the result by the same closing price.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

On July 9, 2025, the reporting person exercised options to purchase 350,000 shares of the issuer's common stock at an exercise price of $1.90 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer withholding 112,521 of the option shares to pay the exercise price and issuing to the reporting person the remaining shares.

Represents shares of common stock acquired upon exercise of 350,000 stock options with an exercise price of $1.90 per share. The number of shares issued was calculated by multiplying the number of options exercised by the preceding day's closing stock price of $5.91 to determine the total stock value, then subtracting the aggregate exercise price, and dividing the result by the same closing price.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $6.00 to $6.11, inclusive. The reporting person undertakes to provide to BTCS, Inc., any security holder of BTCS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence. The securities were sold under a 10b5-1 plan.

Includes shares of restricted common stock subject to forfeiture if certain vesting conditions are not met.

The reported transaction represents a bona-fide gift. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable

As previously disclosed, the Issuer's Board of Directors approved an annual grant of $50,000 of common stock to the Reporting Person to be issued on a quarterly calendar basis ($12,500 per quarter). The grant and any issuances thereunder were exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Board of Directors of the Issuer.

Not applicable

On May 14, 2025, the Reporting Person filed a Form 4, which inadvertently reported that the reported transaction was a purchase using the Code "P" under Table II, column 4. The reported transaction should have been reported under the Code "A". The transaction was approved by an independent committee comprised solely of three non-employee directors as defined in Rule 16b-3(b) under the Securities Exchange Act of 1934.